TL;DR: The real technical challenge is understanding how raw material grade, molecular weight distribution, and free acid fraction interact — and how those interactions determine whether a product performs at 50 kg or collapses at 500 kg
TL;DR: When a brand brief arrives requesting “glycolic acid 10%,” the first thing we pull is the incoming material specification, not the formula card
Key Technical Parameters #
Acid exfoliation formulation decisions come down to more than choosing glycolic over lactic. The real technical challenge is understanding how raw material grade, molecular weight distribution, and free acid fraction interact — and how those interactions determine whether a product performs at 50 kg or collapses at 500 kg. Brand partners working on acid exfoliation actives benefit most from understanding the upstream specification choices that lock in downstream performance. This overview covers the raw material parameters we qualify against before a single lab batch is made.
Raw Material Grade Parameters: What the Spec Sheet Doesn’t Explain #
When a brand brief arrives requesting “glycolic acid 10%,” the first thing we pull is the incoming material specification, not the formula card. The certificate of analysis from a supplier lists purity, but purity alone doesn’t predict formulation behaviour. What matters operationally is the combination of: assay percentage, residual oxalic acid content, heavy metal limits, and water content — and how those shift across different commercial grades.
We run incoming testing against our internal procedure QC-07 Material Risk Assessment, which classifies acid actives into three tiers based on risk of pH drift or preservative interference. Below is how the three most commonly requested cosmetic-grade glycolic acid specifications compare across the parameters we test on every incoming lot.
| Parameter | Industrial/Technical Grade | Cosmetic Grade (Standard) | Cosmetic Grade (High-Purity) |
|---|---|---|---|
| Assay (% glycolic acid) | 70–99% (variable) | ≥99.0% | ≥99.5% |
| Residual oxalic acid | Up to 0.5% | ≤0.1% | ≤0.05% |
| Heavy metals (as Pb) | ≤20 ppm | ≤10 ppm | ≤5 ppm |
| Water content (Karl Fischer) | Not specified | ≤0.5% | ≤0.3% |
| Color (APHA) | ≤50 | ≤20 | ≤10 |
| Iron content | Not controlled | ≤5 ppm | ≤2 ppm |
The iron content row is the one brands consistently overlook. At 5 ppm iron in standard cosmetic grade, you’re introducing a pro-oxidant into any formula that also carries ascorbic acid, niacinamide, or a fragrance with phenolic components. We’ve had three projects in the past two years where unexpected yellowing at week 6 traced back to iron-catalysed oxidation — not the preservative system, not the pH, not the packaging. The culprit was borderline iron content in a glycolic acid lot that passed purity spec but hadn’t been tested for metals at intake.
For brightening and antioxidant formulations that combine acid actives with vitamin C derivatives, we now specify high-purity grade as a baseline. The cost difference per kilogram is real but not the deciding factor — batch failure at week 8 costs considerably more.
Oxalic acid residuals matter for a different reason. Above 0.1%, oxalic acid contributes to erratic pH behaviour during bulk manufacturing. We’ve seen a 500 kg batch drift 0.3 pH units below target during mixing when oxalic content in the glycolic acid lot was on the high end of the acceptable range. That’s enough to push a formula from pH 3.8 to pH 3.5, which changes the free acid fraction and, in the EU regulatory context, can reclassify a leave-on product under EU Cosmetics Regulation 1223/2009. Drop below pH 3.5 and you’re in a grey zone on your safety assessment. We flag this in every formulation kickoff when the target pH is within 0.4 units of a regulatory threshold.
Where Formulations Break Down at Scale — Root Cause Analysis #
Honestly, most scale-up failures with acid systems aren’t formulation failures. They’re specification mismatches that weren’t caught at the raw material stage.
The oxalic acid drift scenario. A leave-on glycolic toner formulated at pH 3.8 in lab used a 500 g sample of high-purity glycolic acid. First production batch used a standard cosmetic grade from a different lot — oxalic residuals at 0.08%, technically within spec, but higher than the lab material. During 300 kg bulk mixing, pH settled at 3.52 rather than 3.8. The formula wasn’t wrong. The material wasn’t out of spec. The spec tolerance was wide enough to allow a real-world outcome no one had modelled. Our current practice is to narrow the oxalic acid acceptance criterion on the approved vendor list to ≤0.06% for any formula targeting pH below 4.2.
The lactic acid enantiomer problem. L-lactic acid and D,L-lactic acid have identical titration assays. You cannot tell them apart from a standard CoA. L-lactic behaves differently on skin — the enzyme-mediated metabolism pathway is enantioselective. A split-face, randomized controlled study (n=40, 8 weeks, published 2020 in the Journal of Cosmetic Dermatology) found that L-lactic acid at 5% produced a 24% improvement in surface roughness versus a 14% improvement for the racemic mixture at the same concentration and pH. When brand partners brief us on a “gentle daily lactic toner,” the first question we ask is whether the on-pack claim will reference L-lactic specifically, because the enantiomer choice changes both the efficacy argument and the supplier shortlist. We’ve seen briefs specify “lactic acid 5%, natural-origin” without realising those two descriptors point at materials with very different enantiomeric ratios depending on fermentation process.
Water content and preservative competition. This one is subtle and we’re still not entirely certain about the mechanism in every case. High water content in the acid raw material — above 0.5% — introduces an unmeasured water load into the aqueous phase calculation. In a toner at 5% total glycolic acid concentration, that translates to roughly 25 g of unaccounted water per kilogram of bulk. Doesn’t sound catastrophic. But in a formula with a tight preservative calculation based on water activity, it can push the system out of the designed efficacy window. We’ve seen a preservative challenge test come back borderline on Candida albicans after batch scale-up when the lab batch passed comfortably. The water content of the acid lot was the variable that changed. We flag this now in what we internally call the Category B moisture sensitivity review, which runs automatically for any preservative system using low-water-activity strategies.
Mandelic acid and particle size in suspension-type formats. Mandelic acid at cosmetic grade typically comes as a crystalline powder. For serums and watery formats, dissolution is not an issue above 40°C. For cold-process formats — which some brands request to preserve heat-sensitive botanicals — undissolved particles at the 1–5 micron range can form over time. We haven’t solved this one cleanly. Our current approach is a minimum 45°C dissolution step even in “cold-process” formulas, followed by cooling under controlled agitation. It works, but it means the cold-process claim needs to be qualified in how we describe the manufacturing protocol.
Does Molecular Weight Actually Matter for Penetration? #
Yes, within a range — but the practical cutoffs are narrower than most supplier literature suggests.
Glycolic acid (molecular weight 76 g/mol) penetrates the stratum corneum faster than mandelic acid (152 g/mol) at equivalent pH and concentration. That’s established. What matters practically is that the penetration rate difference is most significant at pH above 3.5, where the un-ionized fraction is lower and diffusion kinetics dominate. Below pH 3.5, the free acid fraction is high enough across all common AHAs that the molecular weight difference becomes secondary to total free acid concentration. For a daily-use leave-on targeting pH 3.8–4.0, molecular weight selection genuinely affects the sensory and tolerability profile. For a 20% professional peel at pH 2.5, the choice between glycolic and mandelic is more about target cell-type depth than diffusion physics. The FDA Cosmetics Guidelines are largely silent on molecular weight specification, so the technical decision sits entirely with the formulator.
Formulation Notes for Brand Partners #
When you brief us on an acid exfoliation product, the first thing we need is the target market and intended use frequency. Those two inputs determine the regulatory ceiling before we even discuss active concentration.
The most common brief mistake we see is specifying the acid and concentration without specifying the grade or source constraints. “Glycolic acid 8%, vegan, natural-origin” sounds like a complete brief. It’s not. Natural-origin glycolic acid derived from sugarcane fermentation behaves differently from synthetic-route material in terms of oxalic acid residuals and iron content — and the oxalic acid profile is the variable most likely to cause pH instability at scale. We guide partners through grade selection during the first technical call, not after the first stability failure.
Timeline for acid exfoliation projects: lab samples typically 2–3 weeks from brief sign-off, accelerated stability (40°C/75% RH, 8 weeks) running from sample approval, 24-month real-time stability initiated concurrently per ICH Stability Guidelines. If you’re targeting EU, US, and NMPA simultaneously, the NMPA registration file needs stability data that meets NMPA Cosmetic Regulation documentation standards — that’s a parallel workstream, not a sequential one, and it affects timeline planning from day one.
Frequently Asked Questions #
We want “natural-origin” glycolic acid — does that change the spec we should be holding it to?
A: It changes the supplier shortlist significantly. Natural-origin glycolic from sugarcane fermentation routes typically carries higher oxalic acid residuals than synthetic material — we’ve tested incoming lots from four fermentation-route suppliers and the oxalic content ranged 0.04–0.19% across a single supplier’s batches over 12 months. For a pH-sensitive formula, that range is too wide to accept without tightening the acceptance criterion on your approved vendor list. Natural-origin is achievable; it just requires stricter incoming controls than the standard cosmetic grade spec assumes.
Can we use the same glycolic acid grade for a 10% leave-on serum and a 30% professional peel?
A: Technically yes on the raw material, but the qualification burden is completely different. The leave-on at 10% needs to comply with EU Cosmetics Regulation 1223/2009 consumer product limits and requires a full safety assessment. The 30% peel is restricted to professional use in the EU — different labelling, different distribution channel, different liability structure. It depends on which markets you’re selling into, and in some cases a single SKU serving both channels isn’t viable.
What’s the most common stability failure you see in acid formulations after scale-up?
A: pH drift during manufacturing — specifically, target pH settling 0.2–0.4 units below the lab benchmark due to oxalic acid content variation in the acid lot. We’ve seen this consistently enough that we now flag it in the QC-07 risk assessment for any formula with a pH target within 0.5 units of a regulatory threshold. The fix is tightening the incoming spec, not adjusting the formula.
What’s the minimum order quantity for a glycolic acid toner, and how long does sampling take?
A: MOQ on a standard cosmetic format typically starts at 1,000 units for a toner or essence format. Lab samples are ready in 2–3 weeks from confirmed brief; accelerated stability runs 4–8 weeks. If you need NMPA registration documentation, plan an additional 8–12 weeks for that workstream running in parallel.
Should we list the specific acid grade or supplier on our formula card submitted for registration?
A: For China NMPA, yes — the full formula card requires raw material trade name and supplier detail, which means your approved vendor list and your registration file are linked. If you switch glycolic acid supplier post-registration, that can trigger a formula change notification. This is something to plan for at brief stage, not at registration submission. We build the supplier flexibility question into the approved vendor list structure from the start, because it directly affects how much regulatory re-work a supplier change creates later.
Have a product concept in mind? Contact our formulation team to request a complimentary brief review.